NSIS-B.CO Novonesis (Novozymes A/S) B | DK0060336014
| Metric | Current | 31.03.2026 | 31.12.2025 | 30.09.2025 |
|---|---|---|---|---|
| Market Cap | 189.848.289.280 | 178.332.426.877,5 | 189.999.729.221,77 | 181.198.249.180,02 |
| Enterprise Value | 193.280.262.144 | 181.217.526.877,5 | 189.724.429.221,77 | 184.305.849.180,02 |
| Trailing P/E | 42,51 | 388,78 | 426,39 | 443,03 |
| Forward P/E | 23,05 | - | - | - |
| Price to Sales | 45,21 | 56,9 | 61,43 | 58,88 |
| Price to Book | 2,31 | 16,33 | 17,5 | - |
| EV/Revenue | 46,03 | 57,82 | 61,35 | 59,89 |
| EV/EBITDA | 124,96 | 280,05 | 290,45 | 234,78 |